Caitlin John’s West Pharmaceutical WST Stock Holding History

Caitlin John’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31	Closed	-$12.3K	–	958
2024 Q1	$12.3K	Buy	31 +5	+19%	+$1.85K	0.01%	422
2023 Q4	$9.15K	Buy	+26	New	+$9.2K	0.01%	457

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitlin John's WST Position: Q2 2024 in Review

Caitlin John sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 31 shares — an estimated $12.3K sold.

Caitlin John first reported a position in WST in Q4 2023 and held it in 2 quarters. The position peaked at $12.3K in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

Caitlin John reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Caitlin John sold 31 West Pharmaceutical shares in Q2 2024, an estimated $12.3K.
Caitlin John first reported a position in West Pharmaceutical in Q4 2023 and held it in 2 quarters.
Caitlin John's West Pharmaceutical position peaked at $12.3K in Q1 2024.
777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Caitlin John's 13F filing for Q2 2024, filed 27 Jan 2025.